Literature DB >> 12616447

The hepatitis B virus and common mutants.

Stephen Locarnini1, Janine McMillan, Angeline Bartholomeusz.   

Abstract

Most biological systems have developed complex mechanisms to maintain the stability of their genetic information. Exceptions to this include viruses that can undergo rapid and substantial genetic sequence changes and alterations. The hepatitis B virus (HBV) has evolved a unique life cycle resulting in the production of enormous viral loads during active replication without actually directly killing the infected cell. Because the virus uses reverse transcription to copy its DNA genome, mutant viral genomes are frequently found. Particular selection pressures, both endogenous (host immune clearance) and exogenous (vaccines and antivirals), readily select out these escape mutants. It is still not known which particular viral mutations or combination of mutations directly affects the clinical presentation of the liver disease, the nature of the viral persistence, or the course and outcome of chronic infection. Further studies are needed to identify the pathogenic basis for the selection of these mutants. Such research should help improve the basic understanding of this unique virus-host relationship and provide new strategies for complete control of HBV infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616447     DOI: 10.1055/s-2003-37587

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  36 in total

1.  The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection.

Authors:  Fan Li; Xiaodong Li; Tao Yan; Yan Liu; Yongqian Cheng; Zhihui Xu; Qing Shao; Hao Liao; Pengyu Huang; Jin Li; Guo-Feng Chen; Dongping Xu
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

Review 2.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 3.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

Review 5.  Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.

Authors:  Osamu Yokosuka; Makoto Arai
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

6.  Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure.

Authors:  Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-03-28       Impact factor: 6.047

7.  Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes.

Authors:  Xiangdong David Ren; Selena Y Lin; Xiaohe Wang; Tianlun Zhou; Timothy M Block; Ying-Hsiu Su
Journal:  J Virol Methods       Date:  2009-01-31       Impact factor: 2.014

8.  The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B.

Authors:  Tin Nguyen; Paul Desmond; Stephen Locarnini
Journal:  Hepatol Int       Date:  2009-09-18       Impact factor: 6.047

9.  Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Authors:  Frank Tacke; Christina Gehrke; Tom Luedde; Albert Heim; Michael P Manns; Christian Trautwein
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Specific mutations of hepatitis B virus in plasma predict liver cancer development.

Authors:  Shuang-Yuan Kuang; Peta E Jackson; Jin-Bing Wang; Pei-Xing Lu; Alvaro Muñoz; Geng-Sun Qian; Thomas W Kensler; John D Groopman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.